LAWRENCE, Mass., Oct. 3, 2016 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical
technology company focused on advancing renal care, today announced
a three-year agreement with Satellite Healthcare that includes
NxStage's innovative Nx2me Connected Health® platform for their
patients performing home hemodialysis ("HHD") therapy with the
NxStage® System One™. Satellite Healthcare is a national
not-for-profit and the sixth largest provider of patient-centered
dialysis and kidney disease services in the U.S. Under this
agreement, Satellite will roll-out the Nx2me Connected Health
platform to their HHD patients to enhance patient outcomes and
clinician care.
A key component of the Nx2me platform is the Nx2me iPad app,
which is designed to increase patients' ease of use of home therapy
by monitoring and capturing treatment data and wirelessly sending
it to their center after each treatment. Dialysis center
staff can access the treatment data using the Nx2me Clinician
Portal to review and follow treatment adherence and progress.
Importantly, Nx2me patient treatment data can be easily integrated
into EMR systems, thereby reducing the need for paper flow sheets.
By enhancing the ease of information collection and availability to
the patient and care team, Nx2me has been shown to help improve
patient retention on HHD. Recent data showed a 44% lower therapy
discontinuation rate in new patients using the
Nx2me iPad app1.
"This partnership strengthens our Re-Imagine Home goal to change
the landscape of home dialysis with the design of an
industry-leading home dialysis model," said Satellite Healthcare
CEO Rick Barnett. "We identified a
number of ways to empower patients, including how technology like
Nx2me can be a leading factor in removing barriers to choosing and
staying with home dialysis."
"We're delighted that our depth of experience and investment in
breakthrough technologies like Nx2me allow us to give Satellite
Healthcare additional tools to optimize the way they provide
personal care to their patients. We've had a long, successful
relationship with Satellite, and are excited to extend the
partnership to help Satellite continue to lead by example in
the care of home dialysis patients," said Joseph E. Turk, president of NxStage.
For more information about Nx2me and HHD with the NxStage System
One, please visit NxStage.com
Despite the health benefits that home hemodialysis may
provide to those with chronic kidney disease, this form of therapy
is not for everyone. The reported benefits of home hemodialysis may
not be experienced by all patients. The risks associated with
hemodialysis treatments in any environment include, but are not
limited to, high blood pressure, fluid overload, low blood
pressure, heart-related issues, and vascular access complications.
The medical devices used in hemodialysis therapies may add
additional risks including air entering the bloodstream and blood
loss due to clotting or accidental disconnection of the blood
tubing set. Certain risks are unique to the home. Treatments at
home are done without the presence of medical personnel and on-site
technical support. Patients and their partners must be trained on
what to do and how to get medical or technical help if
needed.
1. Weinhandl E, Molina J, Collins A. Lower Risk of Home
Hemodialysis Attrition in Patients Using Nx2me Connected Health
Technology. Abstract presented at Annual Dialysis Conference.
February, 2016.
About Satellite Healthcare
Satellite Healthcare has been among the nation's leading
not-for-profit providers of kidney dialysis and related services
since 1974. Through its affiliated services, Satellite WellBound,
Satellite Dialysis, and Satellite Research, Satellite Healthcare
provides unparalleled early patient wellness education,
personalized clinical services, and a complete range of dialysis
therapy choices. In addition, Satellite Healthcare has a
well-recognized, enduring commitment to philanthropy and community
service, from funding millions of dollars in research grants to
sponsoring kidney programs nationwide. Satellite is committed to
advancing the standard of chronic kidney disease care so patients
can enjoy a better life.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared
specifically by the FDA for home hemodialysis and home
nocturnal hemodialysis. Its simplicity and revolutionary size (just
over a foot tall) are intended to allow convenient use in patients'
homes and give patients the freedom to travel with their therapy.
When combined with the NxStage PureFlow SL Dialysis Preparation
System, patients are able to further simplify, using ordinary tap
water to create dialysis fluid on demand. Unlike conventional
hemodialysis systems, the System One requires no special
infrastructure to operate. Under the guidance of their physician,
patients can use the NxStage System One, with their trained
partners, where, how and when it best meets their needs, including
while they are sleeping - at home or on vacation and at a medically
appropriate treatment frequency. In addition, NxStage's Nx2me
Connected Health platform collects important NxStage System One and
patient information for flexible viewing, monitoring and
reporting that may improve patient management and patient
retention, as well as simplify alternative site care.
http://www.nxstage.com/.
About NxStage Medical
NxStage Medical, Inc.
(Nasdaq: NXTM) is a leading medical technology company,
headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
also has established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's websites
at www.nxstage.com andwww.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including its Quarterly Report on Form 10-Q for
the quarter ended June 30, 2016.
NxStage is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Media contact:
Kristen K. Sheppard,
Esq.
ksheppard@nxstage.com
Tel: (978) 332-5923
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-and-satellite-healthcare-announce-new-three-year-home-hemodialysis-agreement-that-includes-innovative-nx2me-platform-300337807.html
SOURCE NxStage Medical, Inc.